Zika Prevention Strategies: Patient & Community Health - Online
Recording Date: May 25, 2016
Jeffrey Bratberg, PharmD, BCPS, Clinical Professor of Pharmacy Practice University of Rhode Island College of Pharmacy
Paul E. Jarris, MD, MBA, Senior Vice President, Maternal Child Health March of Dimes Foundation
Zika virus, spread primarily through the bite of an infected mosquito, is a growing health threat to people living in, or traveling to, affected areas including Puerto Rico, American Samoa and the U.S. Virgin Islands. Zika virus infection during pregnancy can cause a serious birth defect called microcephaly, as well as other severe fetal brain defects. Rare but serious neurological conditions like Guillain-Barré syndrome are also seen at much higher rates in those infected with Zika. Currently, there is no vaccine available for Zika virus. Health officials focus on prevention strategies that target mosquito bite prevention and avoidance of exposure. This webinar offers community-based pharmacists information on the Zika Virus and discusses prevention measures, community surveillance and effective prevention patient counseling.
The program, "Zika Prevention Strategies: Patience & Community Health," was originally hosted as a live webinar on May 25, 2016. This webinar and the CE credit is open to all interested parties and provided by the NACDS Foundation. One hour of CE credit will be available for this ACPE accredited program following the directions indicated on the Learner Community site.
This course provides pharmacists with knowledge surrounding the Zika virus, risks associated, prevention techniques and how to utilize behavioral counseling to ensure patients are reducing contraction and transmission of the Zika virus.
Recorded Webinar - LENGTH - 60 minutes
NACDS has joined in partnership with March of Dimes and University of Rhode Island College of Pharmacy to offer enduring Continuing Pharmacy Education (CPE) credit to pharmacists who participate in the webinar, and complete the related assessment and evaluation. Please review the information below for detailed steps on how to claim credit. UAN: 0206-0000-16-002-H04-P(0.1 CEUs).
Selection of the program at the bottom of this page titled - Zika Prevention Strategies: Patient & Community Health - Online. Successful completion of the program involves viewing the webinar, passing an assessment with a 70%, and completing an evaluation. Successful completion of this activity will result in 1.0 contact hours of continuing pharmacy education (CPE) credit. Partial credit will not be awarded.
Pharmacists: CPE credit will be awarded for the training course only. This is an knowledge-based activity and is primarily constructed to instill, expand or enhance knowledge through the systematic achievement of specified knowledge, skills, attitudes and performance behaviors.
CPE Monitor, a national, collaborative effort by ACPE and the National Association of Boards of Pharmacy (NABP) to provide an electronic system for pharmacists to track their completed PCE credits, went into effect on Jan. 1, 2013. NACDS, as an ACPE-accredited provider, is required to report pharmacist CPE credit using this new tracking system. Pharmacist participants must provide their NABP e-Profile identification number and date of birth (in MMDD format) when they register for a CPE activity. It will be the responsibility of the pharmacist to provide the correct information (i.e., e-Profile identification number and date of birth in MMDD format). If this information is not provided, NABP and ACPE prohibit NACDS from issuing CPE credit. Online access to their inventory of completed credits will allow pharmacists to easily monitor their compliance with CPE requirements and print statements of credit. Therefore, NACDS will not provide printed statements of credit to pharmacists. If you have not signed up for CPE Monitor, please go to MyCPEMonitor.net.
At the completion of this activity, the participant will be able to:
• Describe what the Zika virus is, how the virus is transmitted, and who is at risk of being infected.
• List the symptoms of Zika virus infection.
• Describe risk of adverse pregnancy or birth outcomes for women infected with Zika.
• Recognize the implications related to sexual transmission of the Zika virus.
• Identify effective methods for prevention of infection and transmission of the Zika virus.
• Describe how pharmacists can use motivational counseling related to Zika prevention.
The National Association of Chain Drug Stores is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.